论文部分内容阅读
目的针对小儿哮喘采用布地奈德混悬液雾化吸入治疗的临床效果进行研究分析。方法将湘西自治州人民医院2012年10月至2013年10月收治的72例哮喘患儿作为研究对象,将其随机分为研究组与参照组,每组36例,参照组进行常规治疗,研究组在参照组的基础上实施布地奈德混悬液雾化吸入治疗,对比两组患儿的治疗效果。结果研究组治疗有效率为97.22%(35例),参照组为72.22%(26例),研究组高于参照组,同时研究组治疗时间明显短于参照组,两组比较差异有统计学意义(P<0.05)。结论针对哮喘患儿采用布地奈德混悬液雾化吸入治疗效果显著,不仅操作简单方便,安全性较高,而且复发率极低,同时无不良反应发生,值得临床应用。
Objective To investigate the clinical effect of inhalation of budesonide suspension for pediatric asthma. Methods A total of 72 asthmatic children from October 2012 to October 2013 in Xiangxi Autonomous Prefecture People’s Hospital were enrolled in this study. They were randomly divided into study group and reference group, with 36 cases in each group. The reference group was treated routinely. The study group On the basis of the reference group, the inhalation of budesonide suspension was performed to compare the therapeutic effect of the two groups of children. Results The effective rate of the study group was 97.22% (35 cases), the reference group was 72.22% (26 cases), the study group was higher than the reference group, while the study group was significantly shorter than the reference group, the difference was statistically significant (P <0.05). Conclusion The treatment of asthma children with budesonide suspension atomization inhalation is effective, not only simple and convenient operation, high safety, but also a very low recurrence rate, and no adverse reactions, it is worth clinical application.